TABLE 4.
Estimated numbers of platelets, plasma, and cryoprecipitated AHF units distributed, transfused, and outdated in 2021 and 2019 (expressed in thousands) in the United States, as reported to the National Blood Collection and Utilization Survey.
| Blood centers |
Hospitals | Combined totals |
95% CI | 2019 totalsa |
% change 2021–2019 |
|
|---|---|---|---|---|---|---|
| Distributed | ||||||
| Apheresis platelets | 2265 | 157 | 2422 | (2298–2545) | 2359 | 2.7% |
| Whole blood-derived plateletsb | 62 | 45 | 107 | (38–175) | 149 | −28.2% |
| Total platelets | 2327 | 202 | 2528 | (2372–2684) | 2508 | 0.8% |
| Pathogen-reduced apheresis platelets | 916 | 35 | 951 | (884–1017) | n/ac | |
| Total plasmad | 2985 | 129 | 3114 | (2929–3298) | 2679 | 16.2% |
| Cryoprecipitated AHFe | 2306 | 143 | 2449 | (2234–2664) | 2304 | 6.3% |
| Blood center outdatesf | 179 | 35 | 214 | (161–267) | 229 | −6.6% |
| Transfused | ||||||
| Apheresis platelets | 2091 | (1919–2264) | 1996 | 4.8% | ||
| Whole blood-derived plateletsb | 80 | (47–112) | 243 | −67.1% | ||
| Total platelets (includes directed units) | 2175 | (1997–2353) | 2243 | −3.0% | ||
| Pathogen-reduced apheresis platelets | 843 | (712–974) | n/ac | |||
| Total plasmad | 2215 | (2084–2347) | 2185 | 1.4% | ||
| Cryoprecipitated AHFe | 1248 | (1075–1421) | 1184 | 5.4% | ||
| Hospital outdatesg | 523 | (468–578) | 500 | 4.6% | ||
a
2019 totals were obtained from the 2019 NBCUS report.5
b
Whole blood-derived platelets are expressed as apheresis equivalents.
c
Estimate not available for 2019.
d
Excludes COVID-19 convalescent plasma.
e
Cryoprecipitated AHF is expressed as individual unit equivalents.
f
Blood center outdates are units that were outdated at non-hospital and hospital-based blood centers.
g
Hospital outdates are units that were outdated at transfusing hospitals.